Biofrontera
BFRI
14 hedge funds and large institutions have $1.97M invested in Biofrontera in 2024 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 0 closing their positions.
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
56% more funds holding
Funds holding: 9 → 14 (+5)
38% more capital invested
Capital invested by funds: $1.43M → $1.97M (+$545K)
3.98% more ownership
Funds ownership: 19.36% → 23.35% (+4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
+$299K |
| 2 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$293K |
| 3 |
Goldman Sachs
New York
|
+$43.1K |
| 4 |
VF
Virtu Financial
New York
|
+$41.7K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$17.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Scotia Capital
Toronto,
Ontario, Canada
|
-$23.6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
RA
1
Rosalind Advisors
Toronto,
Ontario, Canada
| $885K | +$299K | +316,428 | +64% |
|
|
ACM
2
AIGH Capital Management
Baltimore,
Maryland
| $884K | +$293K | +309,663 | +62% |
|
|
3
Goldman Sachs
New York
| $49.7K | +$43.1K | +45,558 | New |
|
|
VF
4
Virtu Financial
New York
| $48K | +$41.7K | +44,106 | New |
|
|
SC
5
Scotia Capital
Toronto,
Ontario, Canada
| $27.3K | -$23.6K | -25,000 | -50% |
|
6
Geode Capital Management
Boston,
Massachusetts
| $21K | +$2.08K | +2,202 | +13% |
|
|
TSS
7
Two Sigma Securities
New York
| $19.7K | +$17.1K | +18,056 | New |
|
8
UBS Group
Zurich,
Switzerland
| $15.3K | +$10.4K | +10,974 | +354% |
|
9
Millennium Management
New York
| $11K | +$9.55K | +10,095 | New |
|
10
BlackRock
New York
| $5.04K | – | – | – |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| $4.95K | +$4.03K | +4,263 | +1,545% |
|
12
Osaic Holdings
Scottsdale,
Arizona
| $627 | – | – | – |
|
|
SS
13
SBI Securities
Tokyo,
Japan
| $334 | +$289 | +306 | New |
|
14
Bank of America
Charlotte,
North Carolina
| $46 | +$17 | +18 | +75% |
|
BFRI Hedge Fund Activity: Q4 2024 in Review
14 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRI) for Q4 2024, worth a combined $1.97M — up 38% from $1.43M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new BFRI positions and 0 closed out — a net gain of 5 holders — while 6 added to existing stakes and 1 trimmed.
The largest buyer was Rosalind Advisors, adding an estimated $299K. The largest seller was Scotia Capital, cutting an estimated $23.6K.
- 14 institutional investors held Biofrontera (BFRI) as of Q4 2024, up from 9 in Q3 2024.
- Funds reported $1.97M of Biofrontera stock for Q4 2024, up 38% quarter-over-quarter.
- 5 funds opened new Biofrontera positions in Q4 2024 and 0 closed out, a net change of +5 holders.
- The largest Biofrontera buyer in Q4 2024 was Rosalind Advisors, an estimated $299K added.
- The largest Biofrontera seller in Q4 2024 was Scotia Capital, an estimated $23.6K sold.
Based on aggregated 13F filings for Q4 2024.